Marta
Llanos Muñoz
Profesora Asociada Asistencial
Hospital General de l'Hospitalet
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de l'Hospitalet (2)
2012
-
First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103
-
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Oncologist, Vol. 17, Núm. 1, pp. 15-25